Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,390.00    0.00 (0.00%)
Bid:
2,000.00
Ask:
2,450.00
Spread: 450.00 (22.50%)
Market Cap: £7.67b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

22 Apr 2026 07:00

RNS Number : 3653B
Bunzl PLC
22 April 2026
 

22 April 2026

BUNZL Q1 TRADING STATEMENT

TRADING CONSISTENT WITH EXPECTATIONS; 2026 GUIDANCE UNCHANGED

 

Bunzl plc, the specialist international distribution and services Group, today announces its trading statement for the three month period to 31 March 2026.

 

Bunzl has delivered a resilient performance in the first quarter against a backdrop of significant macroeconomic and geopolitical uncertainty. Group revenue in the period grew by 1.5% at constant exchange rates, with underlying revenue1 increasing by 2.0%, supported by both volume growth, in part reflective of easier comparatives, and tariff-related price increases. Acquisitions net of disposals contributed growth of 0.6%, while fewer trading days in the period impacted revenue by 1.1%. At actual exchange rates, Group revenue decreased by 0.4%. Adjusted operating profit over the period was consistent with our expectations for a more stable performance in 2026.

 

North America's underlying revenue growth was slightly ahead of the Group, supported by continued benefit of actions taken to improve performance, including new business won in the second half of 2025. Across the other business areas we saw slight underlying revenue growth in aggregate.

 

While the current geopolitical and macroeconomic environment has become more uncertain, we reiterate our 2026 guidance with performance year-to-date consistent with our expectations. We continue to expect moderate revenue growth at constant exchange rates, driven by some underlying revenue growth and a small benefit from acquisitions, and operating margin to be slightly down year-on-year.

 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"The Group continued to deliver underlying revenue growth in the first quarter, supported by actions taken to improve performance and our strengthened focus on organic revenue opportunities. While mindful of the current economic and geopolitical backdrop, the Group reiterates its full year guidance and expects 2026 to be a foundation for future profit growth. Furthermore, there continues to be a significant consolidation opportunity; our pipeline is active and we see an improved outlook for acquisitions in 2026 compared to the prior year. I remain fully confident in our ability to generate long-term compounding growth and value creation for all of our stakeholders."

 

 

 

Enquiries:

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations and Communications

Tel: +44 (0)20 7725 5000

Teneo

Martin Robinson

Kate Somerville

Tel: +44 (0)20 7353 4200

 

 

1. Underlying revenue is organic revenue adjusted for trading days and net of the benefit of hyperinflationary growth in excess of 26% per annum in Turkey, which had no impact over this period.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBSGDSGXDDGLB
Date   Source Headline
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 202510:00 amRNSDividend Declaration
26th Aug 20257:00 amRNSAcquisition
26th Aug 20257:00 amRNSHalf-year Report
5th Aug 20254:25 pmRNSDirector/PDMR Shareholding
1st Aug 20251:01 pmRNSTotal Voting Rights
11th Jul 20255:13 pmRNSDirector/PDMR Shareholding
9th Jul 20255:42 pmRNSDirector/PDMR Shareholding
3rd Jul 20259:24 amRNSDirector/PDMR Shareholding
1st Jul 20254:07 pmRNSDirector/PDMR Shareholding
1st Jul 20254:07 pmRNSTotal Voting Rights
24th Jun 202512:01 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSTrading Statement
18th Jun 20254:47 pmRNSDirector/PDMR Shareholding
5th Jun 20252:25 pmRNSDirector/PDMR Shareholding
2nd Jun 202511:19 amRNSTotal Voting Rights
23rd May 20254:55 pmRNSDirector/PDMR Shareholding
19th May 202512:41 pmRNSDirector/PDMR Shareholding
8th May 20252:38 pmRNSDirector/PDMR Shareholding
7th May 202510:00 amRNSDirector/PDMR Shareholding
7th May 20259:58 amRNSDirector/PDMR Shareholding
6th May 20254:06 pmRNSDirector/PDMR Shareholding
1st May 20253:00 pmRNSBlock listing Interim Review
1st May 20259:42 amRNSTotal Voting Rights
1st May 20258:00 amRNSAdditional Listing
30th Apr 20257:00 amRNSAcquisition
28th Apr 202512:00 pmRNSDirector/PDMR Shareholding
24th Apr 20254:56 pmRNSDirector/PDMR Shareholding
23rd Apr 20255:08 pmRNSDirector/PDMR Shareholding
23rd Apr 20254:35 pmRNSResult of AGM
22nd Apr 202511:19 amRNSDirector/PDMR Shareholding
17th Apr 20254:00 pmRNSDirector/PDMR Shareholding
16th Apr 20258:00 amRNSAdditional Listing
16th Apr 20257:00 amRNSTrading Statement
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20255:35 pmRNSDirector/PDMR Shareholding
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20254:46 pmRNSDirector/PDMR Shareholding
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20253:56 pmRNSDirector/PDMR Shareholding
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20251:47 pmRNSTotal Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.